Obesity's role in MS
An intervention target with possible interactions
Citation Manager Formats
Make Comment
See Comments

Article Information
- First Published December 15, 2020.
Author Disclosures
- Kathryn C. Fitzgerald, ScD and
- Ellen M. Mowry, MD, MCR
- Kathryn C. Fitzgerald, ScD and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NIH NIMH 1-K01MH121582-01, PI, 2019-2023
NONE
Career Transition Fellowship (TA-1805-31136) from the National MS Society
NONE
NONE
NONE
NONE
NONE
NONE
- Ellen M. Mowry, MD, MCR
NONE
NONE
NONE
NONE
NONE
UptoDate chapter editor
NONE
NONE
NONE
NONE
NONE
(1)Free glatiramer acetate for a clinical trial from Teva Neuroscience. (2)Research funding paid to my institution from Biogen and Genzyme (for investigator-initiated studies). (3) Site PI of studies sponsored by Biogen
(1)Department of Defense, W81XWH-16-1-0693 (2)National Institutes of Health, 1R01NR018851-01A1
NONE
1. National Multiple Sclerosis Society. 2. Patient-Centered Outcomes Research Institute (PCORI)
NONE
NONE
NONE
NONE
NONE
NONE
- From the Department of Neurology (K.C.F., E.M.M.), Johns Hopkins School of Medicine; and Department of Epidemiology (K.C.F., E.M.M.), Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
- Correspondence
Dr. Mowry emowry1{at}jhmi.edu
Article usage
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Nicole Sur and Dr. Mausaminben Hathidara
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Article
Overweight/obesity in young adulthood interacts with aspects of EBV infection in MS etiologyAnna Karin Hedström, Nicole Brenner, Julia Butt et al.Neurology: Neuroimmunology & Neuroinflammation, December 15, 2020 -
Articles
Current and past Epstein-Barr virus infection in risk of initial CNS demyelinationR.M. Lucas, A.-L. Ponsonby, K. Dear et al.Neurology, July 13, 2011 -
Article
Elevated EBNA-1 IgG in MS is associated with genetic MS risk variantsKarim L. Kreft, Gijsbert P. Van Nierop, Sandra M.J. Scherbeijn et al.Neurology: Neuroimmunology & Neuroinflammation, October 13, 2017 -
Article
Epstein-Barr virus, cytomegalovirus, and multiple sclerosis susceptibilityA multiethnic studyAnnette Langer-Gould, Jun Wu, Robyn Lucas et al.Neurology, August 30, 2017